{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,5]],"date-time":"2026-09-05T03:15:02Z","timestamp":1788578102796,"version":"build-2803163510"},"reference-count":39,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2021,11,8]],"date-time":"2021-11-08T00:00:00Z","timestamp":1636329600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2021,11,8]],"date-time":"2021-11-08T00:00:00Z","timestamp":1636329600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Int J Obes"],"published-print":{"date-parts":[[2022,3]]},"DOI":"10.1038\/s41366-021-01015-w","type":"journal-article","created":{"date-parts":[[2021,11,8]],"date-time":"2021-11-08T09:02:49Z","timestamp":1636362169000},"page":"486-493","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":23,"title":["Metabolic and genetic determinants for progression to severe liver disease in subjects with obesity from the UK Biobank"],"prefix":"10.1038","volume":"46","author":[{"given":"Antonio","family":"De Vincentis","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Federica","family":"Tavaglione","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rocco","family":"Spagnuolo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Roberta","family":"Pujia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dario","family":"Tuccinardi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gianluca","family":"Mascian\u00e0","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0230-218X","authenticated-orcid":false,"given":"Antonio","family":"Picardi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Raffaele","family":"Antonelli Incalzi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luca","family":"Valenti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9168-4898","authenticated-orcid":false,"given":"Stefano","family":"Romeo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1138-1967","authenticated-orcid":false,"given":"Umberto","family":"Vespasiani-Gentilucci","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2021,11,8]]},"reference":[{"key":"1015_CR1","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1038\/nrgastro.2017.109","volume":"15","author":"Z Younossi","year":"2018","unstructured":"Younossi Z, Anstee QM, Marietti M, Hardy T, Henry L, Eslam M, et al. Global burden of NAFLD and NASH: trends, predictions, risk factors and prevention. Nat Rev Gastroenterol Hepatol. 2018;15:11\u201320.","journal-title":"Nat Rev Gastroenterol Hepatol"},{"key":"1015_CR2","doi-asserted-by":"crossref","unstructured":"European Association for the Study of Diabetes (EASD), European Association for the Study of Obesity (EASO). EASL-EASD-EASO Clinical Practice Guidelines for the management of non-alcoholic fatty liver disease. J Hepatol. 2016;64:1388\u2013402.","DOI":"10.1016\/j.jhep.2015.11.004"},{"key":"1015_CR3","doi-asserted-by":"publisher","first-page":"112","DOI":"10.7326\/0003-4819-132-2-200001180-00004","volume":"132","author":"S Bellentani","year":"2000","unstructured":"Bellentani S, Saccoccio G, Masutti F, Croc\u00e8 LS, Brandi G, Sasso F, et al. Prevalence of and risk factors for hepatic steatosis in Northern Italy. Ann Intern Med. 2000;132:112\u20137.","journal-title":"Ann Intern Med"},{"key":"1015_CR4","doi-asserted-by":"publisher","first-page":"e0171502","DOI":"10.1371\/journal.pone.0171502","volume":"12","author":"EHvanden Berg","year":"2017","unstructured":"Berg EHvanden, Amini M, Schreuder TCMA, Dullaart RPF, Faber KN, Alizadeh, et al. Prevalence and determinants of non-alcoholic fatty liver disease in lifelines: a large Dutch population cohort. PLOS ONE. 2017;12:e0171502.","journal-title":"PLOS ONE"},{"key":"1015_CR5","doi-asserted-by":"publisher","first-page":"124","DOI":"10.1053\/j.gastro.2010.09.038","volume":"140","author":"CD Williams","year":"2011","unstructured":"Williams CD, Stengel J, Asike MI, Torres DM, Shaw J, Contreras M, et al. Prevalence of nonalcoholic fatty liver disease and nonalcoholic steatohepatitis among a largely middle-aged population utilizing ultrasound and liver biopsy: a prospective study. Gastroenterology. 2011;140:124\u201331.","journal-title":"Gastroenterology."},{"key":"1015_CR6","doi-asserted-by":"publisher","first-page":"1017","DOI":"10.1016\/j.metabol.2016.01.012","volume":"65","author":"Y Fazel","year":"2016","unstructured":"Fazel Y, Koenig AB, Sayiner M, Goodman ZD, Younossi ZM. Epidemiology and natural history of non-alcoholic fatty liver disease. Metabolism. 2016;65:1017\u201325.","journal-title":"Metabolism."},{"key":"1015_CR7","doi-asserted-by":"publisher","first-page":"74","DOI":"10.1002\/hep.1840110114","volume":"11","author":"EE Powell","year":"1990","unstructured":"Powell EE, Cooksley WG, Hanson R, Searle J, Halliday JW, Powell LW. The natural history of nonalcoholic steatohepatitis: a follow-up study of forty-two patients for up to 21 years. Hepatology. 1990;11:74\u201380.","journal-title":"Hepatology."},{"key":"1015_CR8","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1111\/apt.14401","volume":"47","author":"S Sookoian","year":"2018","unstructured":"Sookoian S, Pirola CJ. Systematic review with meta-analysis: the significance of histological disease severity in lean patients with nonalcoholic fatty liver disease. Aliment Pharmacol Ther. 2018;47:16\u201325.","journal-title":"Aliment Pharmacol Ther"},{"key":"1015_CR9","doi-asserted-by":"publisher","first-page":"150","DOI":"10.1053\/jhep.2002.33713","volume":"36","author":"S Nair","year":"2002","unstructured":"Nair S, Mason A, Eason J, Loss G, Perrillo RP. Is obesity an independent risk factor for hepatocellular carcinoma in cirrhosis? Hepatology. 2002;36:150\u20135.","journal-title":"Hepatology."},{"key":"1015_CR10","doi-asserted-by":"publisher","first-page":"557","DOI":"10.1016\/S0140-6736(10)62037-5","volume":"377","author":"MM Finucane","year":"2011","unstructured":"Finucane MM, Stevens GA, Cowan M, Danaei G, Lin JK, Paciorek CJ, et al. National, regional, and global trends in body mass index since 1980: Systematic analysis of health examination surveys and epidemiological studies with 960 country-years and 9.1 million participants. Lancet. 2011;377:557\u201367.","journal-title":"Lancet."},{"key":"1015_CR11","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1016\/j.metabol.2018.11.009","volume":"92","author":"C Iacobini","year":"2019","unstructured":"Iacobini C, Pugliese G, Blasetti Fantauzzi C, Federici M, Menini S. Metabolically healthy versus metabolically unhealthy obesity. Metabolism. 2019;92:51\u201360.","journal-title":"Metabolism."},{"key":"1015_CR12","doi-asserted-by":"publisher","first-page":"1286","DOI":"10.1053\/jhep.2003.50229","volume":"37","author":"P Mofrad","year":"2003","unstructured":"Mofrad P, Contos MJ, Haque M, Sargeant C, Fisher RA, Luketic VA, et al. Clinical and histologic spectrum of nonalcoholic fatty liver disease associated with normal ALT values. Hepatology. 2003;37:1286\u201392.","journal-title":"Hepatology."},{"key":"1015_CR13","doi-asserted-by":"publisher","first-page":"1293","DOI":"10.1001\/archinternmed.2010.201","volume":"170","author":"EJ Jacobs","year":"2010","unstructured":"Jacobs EJ, Newton CC, Wang Y, Patel AV, McCullough ML, Campbell PT, et al. Waist circumference and all-cause mortality in a large US cohort. Arch Intern Med. 2010;170:1293\u2013301.","journal-title":"Arch Intern Med"},{"key":"1015_CR14","doi-asserted-by":"publisher","first-page":"280","DOI":"10.1001\/jamacardio.2018.0022","volume":"3","author":"SS Khan","year":"2018","unstructured":"Khan SS, Ning H, Wilkins JT, Allen N, Carnethon M, Berry JD, et al. Association of body mass index with lifetime risk of cardiovascular disease and compression of morbidity. JAMA Cardiol. 2018;3:280\u20137.","journal-title":"JAMA Cardiol"},{"key":"1015_CR15","doi-asserted-by":"publisher","first-page":"1094","DOI":"10.1038\/oby.2004.137","volume":"12","author":"CI Ardern","year":"2004","unstructured":"Ardern CI, Janssen I, Ross R, Katzmarzyk PT. Development of health-related waist circumference thresholds within BMI categories. Obes Res. 2004;12:1094\u2013103.","journal-title":"Obes Res"},{"key":"1015_CR16","doi-asserted-by":"publisher","first-page":"177","DOI":"10.1038\/s41574-019-0310-7","volume":"16","author":"R Ross","year":"2020","unstructured":"Ross R, Neeland IJ, Yamashita S, Shai I, Seidell J, Magni P, et al. Waist circumference as a vital sign in clinical practice: a Consensus Statement from the IAS and ICCR Working Group on Visceral Obesity. Nat Rev Endocrinol. 2020;16:177\u201389.","journal-title":"Nat Rev Endocrinol"},{"key":"1015_CR17","doi-asserted-by":"publisher","first-page":"e1001779","DOI":"10.1371\/journal.pmed.1001779","volume":"12","author":"C Sudlow","year":"2015","unstructured":"Sudlow C, Gallacher J, Allen N, Beral V, Burton P, Danesh J, et al. UK biobank: an open access resource for identifying the causes of a wide range of complex diseases of middle and old age. PLoS Med. 2015 Mar;12:e1001779.","journal-title":"PLoS Med"},{"key":"1015_CR18","doi-asserted-by":"publisher","first-page":"234","DOI":"10.1093\/ije\/dym276","volume":"37","author":"P Elliott","year":"2008","unstructured":"Elliott P, Peakman TC. UK Biobank. The UK Biobank sample handling and storage protocol for the collection, processing and archiving of human blood and urine. Int J Epidemiol. 2008;37:234\u201344.","journal-title":"Int J Epidemiol"},{"key":"1015_CR19","doi-asserted-by":"publisher","first-page":"203","DOI":"10.1038\/s41586-018-0579-z","volume":"562","author":"C Bycroft","year":"2018","unstructured":"Bycroft C, Freeman C, Petkova D, Band G, Elliott LT, Sharp K, et al. The UK Biobank resource with deep phenotyping and genomic data. Nature. 2018;562:203\u20139.","journal-title":"Nature."},{"key":"1015_CR20","doi-asserted-by":"publisher","first-page":"223","DOI":"10.1038\/s41575-020-00381-6","volume":"18","author":"DQ Huang","year":"2021","unstructured":"Huang DQ, El-Serag HB, Loomba R. Global epidemiology of NAFLD-related HCC: trends, predictions, risk factors and prevention. Nat Rev Gastroenterol Hepatol. 2021;18:223\u2013238. https:\/\/doi.org\/10.1038\/s41575-020-00381-6.","journal-title":"Nat Rev Gastroenterol Hepatol"},{"key":"1015_CR21","doi-asserted-by":"publisher","first-page":"2769","DOI":"10.1016\/j.cgh.2019.04.038","volume":"17","author":"K Bj\u00f6rkstr\u00f6m","year":"2019","unstructured":"Bj\u00f6rkstr\u00f6m K, Franz\u00e9n S, Eliasson B, Miftaraj M, Gudbj\u00f6rnsdottir S, Trolle-Lagerros Y, et al. Risk factors for severe liver disease in patients with type 2 diabetes. Clin Gastroenterol Hepatol. 2019;17:2769\u20132775.e4.","journal-title":"Clin Gastroenterol Hepatol"},{"key":"1015_CR22","doi-asserted-by":"crossref","unstructured":"Tavaglione F, De Vincentis A, Jamialahmadi O, Pujia R, Spagnuolo R, Picardi A, et al. Inborn and acquired risk factors for severe liver disease in Europeans with type 2 diabetes from the UK Biobank. JHEP Rep. 2021;100262.","DOI":"10.1016\/j.jhepr.2021.100262"},{"key":"1015_CR23","doi-asserted-by":"publisher","first-page":"2105","DOI":"10.1056\/NEJMoa0801891","volume":"359","author":"T Pischon","year":"2008","unstructured":"Pischon T, Boeing H, Hoffmann K, Bergmann M, Schulze MB, Overvad K, et al. General and abdominal adiposity and risk of death in Europe. N Engl J Med. 2008;359:2105\u201320.","journal-title":"N Engl J Med"},{"key":"1015_CR24","doi-asserted-by":"publisher","first-page":"335","DOI":"10.1016\/j.mayocp.2013.11.011","volume":"89","author":"JR Cerhan","year":"2014","unstructured":"Cerhan JR, Moore SC, Jacobs EJ, Kitahara CM, Rosenberg PS, Adami H-O, et al. A pooled analysis of waist circumference and mortality in 650,000 adults. Mayo Clin Proc. 2014;89:335\u201345.","journal-title":"Mayo Clin Proc"},{"key":"1015_CR25","doi-asserted-by":"publisher","first-page":"1658","DOI":"10.1161\/CIRCULATIONAHA.107.739714","volume":"117","author":"C Zhang","year":"2008","unstructured":"Zhang C, Rexrode KM, van Dam RM, Li TY, Hu FB. Abdominal obesity and the risk of all-cause, cardiovascular, and cancer mortality: sixteen years of follow-up in US women. Circulation. 2008;117:1658\u201367.","journal-title":"Circulation."},{"key":"1015_CR26","doi-asserted-by":"publisher","first-page":"1298","DOI":"10.1038\/ejcn.2013.203","volume":"67","author":"X Song","year":"2013","unstructured":"Song X, Jousilahti P, Stehouwer CDA, S\u00f6derberg S, Onat A, Laatikainen T, et al. Comparison of various surrogate obesity indicators as predictors of cardiovascular mortality in four European populations. Eur J Clin Nutr. 2013;67:1298\u2013302.","journal-title":"Eur J Clin Nutr"},{"key":"1015_CR27","doi-asserted-by":"crossref","unstructured":"Jarvis H, Craig D, Barker R, Spiers G, Stow D, Anstee QM, et al. Metabolic risk factors and incident advanced liver disease in non-alcoholic fatty liver disease (NAFLD): a systematic review and meta-analysis of population-based observational studies. PLoS Med [Internet]. 2020.;17(4). https:\/\/www.ncbi.nlm.nih.gov\/pmc\/articles\/PMC7192386\/. Accessed 22 Mar 2021.","DOI":"10.1371\/journal.pmed.1003100"},{"key":"1015_CR28","doi-asserted-by":"publisher","first-page":"531","DOI":"10.1016\/j.jhep.2018.10.033","volume":"70","author":"ZM Younossi","year":"2019","unstructured":"Younossi ZM. Non-alcoholic fatty liver disease\u2014a global public health perspective. J Hepatol. 2019;70:531\u201344.","journal-title":"J Hepatol"},{"key":"1015_CR29","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3350\/cmh.2016.0109","volume":"23","author":"S Sookoian","year":"2017","unstructured":"Sookoian S, Pirola CJ. Genetic predisposition in nonalcoholic fatty liver disease. Clin Mol Hepatol. 2017;23:1\u201312.","journal-title":"Clin Mol Hepatol"},{"key":"1015_CR30","doi-asserted-by":"publisher","first-page":"1634","DOI":"10.1053\/j.gastro.2020.12.023","volume":"160","author":"O Jamialahmadi","year":"2020","unstructured":"Jamialahmadi O, Mancina RM, Ciociola E, Tavaglione F, Luukkonen PK, Baselli G. et al.Exome-wide association study on alanine aminotransferase identifies sequence variants in the GPAM and APOE associated with fatty liver disease.Gastroenterology. 2020;160:1634\u20131646.e7. https:\/\/doi.org\/10.1053\/j.gastro.2020.12.023. Epub 2021 Feb 6.","journal-title":"Gastroenterology"},{"key":"1015_CR31","doi-asserted-by":"publisher","first-page":"1934","DOI":"10.1111\/liv.14543","volume":"40","author":"A De Vincentis","year":"2020","unstructured":"De Vincentis A, Mancina RM, Pihlajam\u00e4ki J, M\u00e4nnist\u00f6 V, Petta S, Dongiovanni P, et al. Genetic variants in the MTHFR are not associated with fatty liver disease. Liver Int.2020;40:1934\u201340.","journal-title":"Liver Int."},{"key":"1015_CR32","doi-asserted-by":"publisher","first-page":"4835","DOI":"10.3748\/wjg.v24.i43.4835","volume":"24","author":"U Vespasiani-Gentilucci","year":"2018","unstructured":"Vespasiani-Gentilucci U, Gallo P, Dell\u2019Unto C, Volpentesta M, Antonelli-Incalzi R, Picardi A. Promoting genetics in non-alcoholic fatty liver disease: combined risk score through polymorphisms and clinical variables. World J Gastroenterol. 2018;24:4835\u201345.","journal-title":"World J Gastroenterol"},{"key":"1015_CR33","doi-asserted-by":"publisher","first-page":"356","DOI":"10.1111\/joim.12719","volume":"283","author":"P Dongiovanni","year":"2018","unstructured":"Dongiovanni P, Stender S, Pietrelli A, Mancina RM, Cespiati A, Petta S, et al. Causal relationship of hepatic fat with liver damage and insulin resistance in nonalcoholic fatty liver. J Intern Med. 2018;283:356\u201370.","journal-title":"J Intern Med"},{"key":"1015_CR34","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1016\/j.cmet.2019.12.002","volume":"31","author":"S Romeo","year":"2020","unstructured":"Romeo S, Sanyal A, Valenti L. Leveraging human genetics to identify potential new treatments for fatty liver disease. Cell Metab. 2020;31:35\u201345.","journal-title":"Cell Metab"},{"key":"1015_CR35","doi-asserted-by":"publisher","first-page":"775","DOI":"10.1016\/j.jhep.2020.11.024","volume":"74","author":"C Bianco","year":"2021","unstructured":"Bianco C, Jamialahmadi O, Pelusi S, Baselli G, Dongiovanni P, Zanoni I, et al. Non-invasive stratification of hepatocellular carcinoma risk in non-alcoholic fatty liver using polygenic risk scores. J Hepatol. 2021;74:775\u201382.","journal-title":"J Hepatol"},{"key":"1015_CR36","first-page":"00595","volume":"S1542-3565","author":"A De Vincentis","year":"2021","unstructured":"De Vincentis A, Tavaglione F, Jamialahmadi O, Picardi A, Antonelli Incalzi R, Valenti L, et al. A polygenic risk score to refine risk stratification and prediction for severe liver disease by clinical fibrosis scores. Clin Gastroenterol Hepatol. 2021;S1542-3565:00595\u20134.","journal-title":"Clin Gastroenterol Hepatol"},{"key":"1015_CR37","doi-asserted-by":"publisher","first-page":"158","DOI":"10.1136\/bmj.311.6998.158","volume":"311","author":"ME Lean","year":"1995","unstructured":"Lean ME, Han TS, Morrison CE. Waist circumference as a measure for indicating need for weight management. BMJ. 1995;311:158\u201361.","journal-title":"BMJ."},{"key":"1015_CR38","doi-asserted-by":"publisher","first-page":"22","DOI":"10.1093\/aje\/kwr048","volume":"174","author":"D Sluik","year":"2011","unstructured":"Sluik D, Boeing H, Montonen J, Pischon T, Kaaks R, Teucher B, et al. Associations between general and abdominal adiposity and mortality in individuals with diabetes mellitus. Am J Epidemiol. 2011;174:22\u201334.","journal-title":"Am J Epidemiol"},{"key":"1015_CR39","doi-asserted-by":"publisher","first-page":"1540","DOI":"10.1093\/ajcn\/85.6.1540","volume":"85","author":"JL Kuk","year":"2007","unstructured":"Kuk JL, Janiszewski PM, Ross R. Body mass index and hip and thigh circumferences are negatively associated with visceral adipose tissue after control for waist circumference. Am J Clin Nutr. 2007;85:1540\u20134.","journal-title":"Am J Clin Nutr"}],"container-title":["International Journal of Obesity"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41366-021-01015-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41366-021-01015-w","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41366-021-01015-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,4,9]],"date-time":"2025-04-09T10:39:58Z","timestamp":1744195198000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41366-021-01015-w"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,11,8]]},"references-count":39,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2022,3]]}},"alternative-id":["1015"],"URL":"https:\/\/doi.org\/10.1038\/s41366-021-01015-w","relation":{},"ISSN":["0307-0565","1476-5497"],"issn-type":[{"value":"0307-0565","type":"print"},{"value":"1476-5497","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,11,8]]},"assertion":[{"value":"12 July 2021","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 October 2021","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 October 2021","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 November 2021","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"SR has served as a consultant for AstraZeneca, Celgene, Sanofi, Amgen, Akcea Therapeutics, Camp4, Medacorp, and Ambys in the last 3 years. SR has received research grants from AstraZeneca in the last 2 years. The others declare no financial or other relationships with drug manufacturers that could lead to a conflict of interest.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}